The original antiplatelet, with a three-level mechanism of action and organ-protective effects, minimal risk of hemorrhages.
A unique combination of four natural brain metabolites that regulate the processes of hyper-excitability and improve cognitive functions in the most physiological and comprehensive way.
Prescription drug contains a unique strain of Escherichia coli Nissle 1917 in the amount of 2.5 – 25 * 109 CFU, which, due to its unique anti-inflammatory properties, is the most studied bacterial strain today. Approved for use in pregnant and lactating women, is widely used in Germany and around the world.
Prescription drug, contains a unique strain of Escherichia coli Nissle 1917 in the amount of 108 CFU, approved for use from the 1st day of life in newborns, including premature infants.
Nucleo CMP – a combination of pyrimidine nucleotides, provides restoration of the structure and function of peripheral nerves, eliminates the symptoms of neuropathy, reduces the need for analgesics.
Nucleo CMP – a combination of pyrimidine nucleotides, provides restoration of the structure and function of peripheral nerves, eliminates the symptoms of neuropathy, reduces the need for analgesics.
Rectal form of prednisone, a drug for intensive treatment of acute stenosinglaryngotracheitis, croup, spastic bronchitis. Approved for use in children from 6 months.
Original Spanish citicoline. World expert in citicolines with 40 years of application, i.e. of the highest qualification; provides neuroprotection, neuroreparation at hypoxia and traumatic brain damage.
Original Spanish citicoline. World expert in citicolines, an effective neuroprotector in the treatment and rehabilitation of over 1-year old children with organic lesions of the central nervous system.
The original drug, has a high content of carnitine and lysine, allows for the fast results in treating appetite disorders, asthenia and weight deficit. Metopine contained in the drug, improves appetite and has a calming effect.
European innovation in the treatment of lymphatic venous insufficiency. The original technology of increasing the bioavailability of bioflavonoids that provides an effective and rapid reduction of all the symptoms of CVI, while reducing the number of side effects.
